Results 1 to 10 of about 2,106 (125)

Deciphering molecular determinants of GPBAR1-Gs protein interactions by HDX-MS and cryo-EM [PDF]

open access: yesScientific Reports
Many physiological processes are dependent on G protein-coupled receptors (GPCRs), the biggest family of human membrane proteins and a significant class of therapeutic targets.
Jérôme Castel   +11 more
exaly   +3 more sources

GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation

open access: yesCells, 2022
Background & Aims: ACE2, a carboxypeptidase that generates Ang-(1-7) from Ang II, is highly expressed in the lung, small intestine and colon. GPBAR1, is a G protein bile acid receptor that promotes the release of the insulinotropic factor glucagon-like ...
Cristina Di Giorgio   +2 more
exaly   +3 more sources

Gpbar1-mediated SIRT1-PGC-1α axis maintains mitochondrial homeostasis and mitigates renal injury in obstructive jaundice [PDF]

open access: yesScientific Reports
Obstructive jaundice (OJ)-induced kidney injury has a high mortality rate, severely affecting patient prognosis. Gpbar1, a bile acid receptor, plays a key role in maintaining tissue homeostasis in organs such as the liver and pancreas during OJ. However,
Mingchen Li   +7 more
doaj   +2 more sources

Multi-omics profiling identifies M1 macrophage polarization-associated biomarkers in hepatitis B virus-related acute-on-chronic liver failure [PDF]

open access: yesFrontiers in Microbiology
Background and aimsM1 macrophage polarization is essential for the progression of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF).
Chengxi Sun   +9 more
doaj   +2 more sources

A bile acid–GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis [PDF]

open access: yesGut Microbes
Intestinal fibrosis is a severe complication of Crohn's disease for which therapy remains suboptimal. Probiotics are widely used in the treatment of intestinal inflammation, but all major guidelines do not recommend in favor of their use, with the ...
Michele Biagioli   +14 more
doaj   +2 more sources

Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases

open access: yesPharmacological Research
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic disorders characterized by dysregulated immune response and persistent inflammation.
Martina Bordoni, Eleonora Distrutti
exaly   +3 more sources

Roles of Bile Acid-Activated Receptors in Monocytes-Macrophages and Dendritic Cells [PDF]

open access: yesCells
Bile acids (BAs), essential for lipid metabolism and fat-soluble vitamin absorption, also act as signaling molecules that regulate immune homeostasis.
Huilin Jia   +3 more
doaj   +2 more sources

Mechanistic study of deoxycholic acid in colorectal cancer based on network toxicology and machine learning approaches [PDF]

open access: yesBMC Pharmacology and Toxicology
Objective This study aims to explore the mechanistic role of deoxycholic acid (DCA) in colorectal cancer (CRC) through the integration of network toxicology and machine learning approaches.
Yulai Yin   +5 more
doaj   +2 more sources

Phocaeicola dorei YGMCC0564 attenuates HFD-induced glycolipid metabolic disorders in association with remodeling of the gut microbiota and bile acid profiles [PDF]

open access: yesFrontiers in Microbiology
BackgroundGlycolipid Metabolic Disorders (GLMD) are characterized by imbalances in glucose and lipid homeostasis, often presenting with severe clinical symptoms.
Zhili He   +7 more
doaj   +2 more sources

Epigallocatechin-3-gallate supplementation regulates glucose redistribution through its potential endogenous receptor in grass carp (Ctenopharyngodon idella) [PDF]

open access: yesAnimal Nutrition
Exploring exogenous additives to enhance non-protein energy ingredient utilization in fish is highly anticipated. Epigallocatechin-3-gallate (EGCG) is a prominent polyphenol found in green tea.
Fan Chen   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy